The clinical importance of WNT5A is highlighted by previous results revealing increased expression of WNT5A at both the mRNA and protein levels in clinical melanoma samples compared to normal samples, suggesting that WNT5A promotes melanoma progression [11, 12]. This evidence concerns the gene WNT5A and melanoma.